| Periode | Prosjekttittel | Prosjektleder |
|---|---|---|
| 2012 - 2017 | Late effects - early detection, follow-up and treatmentLate effects - early detection, follow-up and treatment | Jon Håvard Loge |
| 2012 - 2015 | Personalized Cancer MedicinePersonalized Cancer Medicine | Ola Myklebost |
| 2012 - 2016 | MetAction: Actionable Targets in Cancer Metastasis - from Bed to Bench to Byte to BedsideMetAction: Actionable Targets in Cancer Metastasis - from Bed to Bench to Byte to Bedside | Gunhild Mari Mælandsmo |
| 2009 - 2013 | CD20-specific T cell receptors in gene therapy of leukemia and lymphomaCD20-specific T cell receptors in gene therapy of leukemia and lymphoma | Johanna Olweus |
| 2009 - 2013 | Molecular alterations and targeted therapy in Endometrial CancerMolecular alterations and targeted therapy in Endometrial Cancer | Helga Birgitte Salvesen |
| 2009 - 2012 | Molecular and biological characterization of cancer metastasesMolecular and biological characterization of cancer metastases | Øystein Fodstad |
| 2009 - 2012 | Integration of clinical and basic research to improve treatment of multiple myelomaIntegration of clinical and basic research to improve treatment of multiple myeloma | Anders Sundan |
| 2009 - 2012 | Understanding Breast Cancer Genomics; Towards combined molecular profiles for better diagnosis and treatmentUnderstanding Breast Cancer Genomics; Towards combined molecular profiles for better diagnosis and treatment | Anne-Lise Børresen-Dale |
| 2009 - 2014 | Aspects of breast cancer risk: subtypes of breast cancer, relation to angiogenic factors and gene-environment interactionsAspects of breast cancer risk: subtypes of breast cancer, relation to angiogenic factors and gene-environment interactions | Lars J. Vatten |
| 2009 - 2013 | Somatic, translational and psychosocial research in long-term cancer survivorsSomatic, translational and psychosocial research in long-term cancer survivors | Jon Håvard Loge |
| 2009 - 2012 | Translational research directed toward identification of the mechanisms of chemoresistance in breast cancer.Translational research directed toward identification of the mechanisms of chemoresistance in breast cancer. | Per Eystein Lønning |
| 2009 - 2012 | Development of biomarkers and identification of therapeutic targets for prostate carcinogenesisDevelopment of biomarkers and identification of therapeutic targets for prostate carcinogenesis | Fahri Saatcioglu |
| 2005 - 2012 | EURAMOS- KREFTEURAMOS- KREFT | Sigbjørn Smeland |
Norges forskningsråd
Postboks 2700 St. Hanshaugen 0131 Oslo
Besøksadresse: Stensberggata 26
Telefon: 22 03 70 00
Telefaks: 22 03 70 01
E-post:
post@forskningsradet.no
Henvendelser om nettsidene:
webmaster@forskningsradet.no